276 related articles for article (PubMed ID: 10968692)
1. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
[TBL] [Abstract][Full Text] [Related]
3. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
5. [MPO-positive cells and extracellular MPO in the glomeruli of MPO-ANCA-associated glomerulonephritis].
Kawashima S; Arimura Y; Nakabayashi K; Yamada A
Nihon Jinzo Gakkai Shi; 2009; 51(1):56-67. PubMed ID: 19238910
[TBL] [Abstract][Full Text] [Related]
6. Glomerular lesions in patients with Churg-Strauss syndrome and the anti-myeloperoxidase antibody.
Kikuchi Y; Ikehata N; Tajima O; Yoshizawa N; Miura S
Clin Nephrol; 2001 Jun; 55(6):429-35. PubMed ID: 11434353
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis superimposed on biopsy-proven diabetic nephrosclerosis.
Ninomiya T; Kanai H; Hirakawa M; Arimura Y; Masutani K; Kashiwagi M; Nakamura S; Koga Y; Fukuda K; Hirakata H
Am J Kidney Dis; 2002 Jan; 39(1):E4. PubMed ID: 11774130
[TBL] [Abstract][Full Text] [Related]
10. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
11. [A case of crescentic glomerulonephritis associated with anti-myeloperoxidase antibody presenting as alveolar hemorrhage].
Umino T; Ohdama S; Sawada M; Takano S; Miyake S; Tachibana S; Yoshizawa Y; Aoki N; Matsubara O; Tanaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):277-82. PubMed ID: 8189651
[TBL] [Abstract][Full Text] [Related]
12. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
13. [Clinical investigation of anti-myeloperoxidase antibodies in patients with glomerulonephritis with crescent formation].
Arimura Y; Nohmi K; Tanaka U; Nagasawa T
Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1087-93. PubMed ID: 1962827
[TBL] [Abstract][Full Text] [Related]
14. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
15. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
[TBL] [Abstract][Full Text] [Related]
16. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Yamashita K; Yorioka N; Kyuden Y; Naito T; Tanji C; Ueda C; Usui K; Shigemoto K; Harada S; Yamakido M
Clin Nephrol; 2000 Apr; 53(4):296-300. PubMed ID: 10809419
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T
Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328
[TBL] [Abstract][Full Text] [Related]
18. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
Fujii A; Tomizawa K; Arimura Y; Nagasawa T; Ohashi YY; Hiyama T; Mizuno S; Suzuki K
Clin Nephrol; 2000 Apr; 53(4):242-52. PubMed ID: 10809410
[TBL] [Abstract][Full Text] [Related]
19. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
Arimura Y; Minoshima S; Kamiya Y; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Sasaki T; Suzuki K
Clin Nephrol; 1993 Nov; 40(5):256-64. PubMed ID: 8281714
[TBL] [Abstract][Full Text] [Related]
20. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yoshimura J; Fukami K; Koike K; Nagano M; Matsumoto T; Iwatani R; Kusumoto T; Hazama T; Ueda S; Adachi H; Hirai Y; Takasu K; Ohshima K; Yamagishi S; Okuda S
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):879-83. PubMed ID: 20528980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
